Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
6
×
clinical trials
fda
6
×
life sciences
national blog main
6
×
san francisco blog main
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
drugs
eli lilly
investing
loxo oncology
nonalcoholic steatohepatitis
startups
abbvie
astrazeneca
bladder cancer
What
drug
6
×
cancer
biotech
fda
roundup
annual
approved
attention
bio
companies
medicine
new
research
targets
ahead
alzheimer’s
ambien
american
asco
assessed
attendees
black
camp’s
cash
chicago
city
clinic
clinical
combinations
communities
community’s
conference
days
deeper
diamond
digital
disease
dna
eisai
eluded
Language
unset
Current search:
fda
×
drug
×
" national blog main "
×
cancer
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More